Anti-VEGF Receptor 2 (phospho Y1214) 抗体
Anti-VEGF Receptor 2 (phospho Y1214) antibody
Be the first to review this product! Submit a review
|
(12 Publications)
Rabbit Polyclonal VEGF Receptor 2 phospho Y1214 antibody. Suitable for WB and reacts with Synthetic peptide - Human, Human samples. Cited in 12 publications.
別名を表示する
CD309, FLK1, VEGFR2, KDR, Vascular endothelial growth factor receptor 2, VEGFR-2, Fetal liver kinase 1, Kinase insert domain receptor, Protein-tyrosine kinase receptor flk-1, FLK-1
- WB
Supplier Data
Western blot - Anti-VEGF Receptor 2 (phospho Y1214) antibody (AB5475)
Modulation of expression of target protein by cell treatment to demonstrate antibody specificity.
The membrane was probed with the relevant primary and secondary Antibody following blocking with 5 % skimmed milk. Chemiluminescent detection was performed using Pierce™ ECL Western Blotting Substrate
All lanes:
Western blot - Anti-VEGF Receptor 2 (phospho Y1214) antibody (ab5475) at 1/1000 dilution
Lane 1:
HT-29 (Human colorectal adenocarcinoma cell line) whole cell lysate at 30 µg
Lane 2:
HT-29 Serum Starved followed by treatment for 10 minutes with 100 ng/mL of SCF at 30 µg
Lane 3:
Caco-2 (Human colorectal adenocarcinoma cell line) whole cell lysate at 30 µg
Lane 4:
Caco-2 Serum Starved followed by treatment for 10 minutes with 100 ng/mL of SCF at 30 µg
Secondary
All lanes:
Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1/5000 dilution
Predicted band size: 151 kDa
Observed band size: ~151 kDa
false
- WB
Unknown
Western blot - Anti-VEGF Receptor 2 (phospho Y1214) antibody (AB5475)
Peptide Competition and Stimulation : Extracts prepared from CSF-1 stimulated (1-4, 6) or unstimulated (5) PAE cells transfected with a chimeric CSF-1/VEGFR2 receptor were resolved by SDS-PAGE on a 10% polyacrylamide gel and transferred to PVDF. Membranes were blocked with a 5% BSA-TBST buffer overnight at 4°C, then were incubated with 0.50 μg/mL ab5475 antibody for two hours at room temperature in a 3% BSA-TBST buffer, following prior incubation with : no peptide (1, 5, 6), the nonphosphopeptide corresponding to the immunogen (2), a generic phosphotyrosine containing peptide (3), or, the phosphopeptide immunogen (4). After washing, membranes were incubated with goat F(ab’)2 anti-rabbit IgG alkaline phosphatase and bands were detected using the Tropix WesternStar method. The data show that only the peptide corresponding to ab5475 blocks the antibody signal, and the stimulation of the phospho signal after stimulating ligand is added (CSF-1 for the chimeric r
All lanes:
Western blot - Anti-VEGF Receptor 2 (phospho Y1214) antibody (ab5475)
Predicted band size: 151 kDa
false
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
精製に関する特記事項
バッファー組成
出荷温度
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
VEGF Receptor 2 is important for angiogenesis and vascular permeability. It is part of the VEGF receptor family which also includes VEGF Receptors 1 and 3 forming a complex interaction network. Upon binding with VEGF it phosphorylates key proteins to initiate signals that regulate endothelial cell migration proliferation and survival. The receptor's function is critical for normal developmental processes and wound healing as well.
Pathways
VEGF Receptor 2 is especially important within the angiogenesis and vascular permeability pathways. It plays a central role in the VEGF signaling pathway alongside proteins like VEGF A which is the primary ligand for the receptor. The signaling through this receptor modulates various downstream proteins through phosphorylation linking it to pathways that control cellular responses essential for blood vessel formation and maintenance.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (12)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 15:5986 PubMed39013903
2024
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 9:1743 PubMed35071437
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 295:11466-11472 PubMed32518161
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 10:131 PubMed30755600
2019
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federa 31:2001-2012 PubMed28183800
2017
Applications
Unspecified application
Species
Unspecified reactive species
Developmental biology 408:41-55 PubMed26455409
2015
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 10:11 PubMed23339567
2013
Applications
IHC
Species
Unspecified reactive species
Developmental dynamics : an official publication o 241:684-96 PubMed22354878
2012
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical endocrinology and metaboli 96:E1973-81 PubMed21994955
2011
Applications
WB, IHC
Species
Human, Human
BMC developmental biology 10:13 PubMed20105280
2010
Applications
IHC
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com